Skip to main content
OpenTrials
Completed

NCT Number: NCT05895227

Hemorrhagic Complications of Transvaginal Oocyte's Retrieval: an Update.

The goal of this retrospective analysis is to focus on peritoneal bleeding after oocyte retrieval and to further investigate factors related to this specific complication and if hemorrhagic complication rate modifications can be observed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ART Genital Diseases Infertility Urogenital Diseases

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

About this study

The main aim is to update our knowledge on oocyte retrieval complication, focusing specifically on hemorrhagic / hemoperitoneum rate.

All retrievals will be retrieved in IVF/ICSI cycles and Fertility Preservation both in oncological patients and in patients requesting oocyte storage for deferring motherhood.

Data collection goes from January 2017 to December 2022.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients that underwent a procedure of oocyte transvaginal retrieval for IVF/ intracytoplasmatic sperm injection (ICSI) cycles and fertility preservation

Exclusion criteria

-

Treatment and study plan

Oocyte retrieval

Procedure

Primary outcomes

  1. Hemoperitoneum after oocyte transvaginal retrieval

    Time frame: Oocyte retrievals in the period January 2017- December 2022

    number of patients with onset of hemoperitoneum

Secondary outcomes

  1. Operator of the procedure

    Time frame: 6 years

    assessment of operator experience

  2. Hemoglobin level before and after procedure

    Time frame: 6 years

    evaluation of hemoglobin level before and the day after procedure

  3. Time of symptoms onset

    Time frame: 6 years

    evaluation of first symptoms onset

  4. Loss of blood during procedure

    Time frame: 6 years

    average blood loss

  5. Incidence compared to past case history

    Time frame: 6 years

    comparison with previous statistic

  6. Need for hospitalization

    Time frame: 6 years

    patients requiring hospitalisation

Sponsors and collaborators

Lead sponsor

Istituto Clinico Humanitas

Other

Registry information

Important dates

Study start
2017
Primary completion
2022
Study completion
2022
First posted
Jun 8, 2023
Registry last updated
Jun 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.